Skip to main content

Advanced Search

Projected result for your current search:: 0

Search Operators:

You can use operators in your search query to narrow down your results even more. Click on the search operator to see an explanation of how it works.
Finds documents with exactly this word group, in exactly this word order and spelling (e.g. "employer branding").
Finds documents with both search terms (e.g. sales AND bonus).
Finds documents with one or the other search term (e.g. porsche OR volkswagen).
Finds documents with all search terms. Blank space is understood as AND (e.g. man robot production).
Finds documents with no appearance of the word behind NOT (e.g. ford NOT "harrison ford").
Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g. COUNT(gear)>8).
Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g. NEAR(recruit, professionals, 20)).
Finds documents with the search term in word versions or composites. The asterisk * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g. lightweight*, *lightweight, *lightweight*).
Finds documents with the search term in different spellings. "?" allows only one character (e.g. organi?ation).
Special characters are understood as AND (e.g. Miller Bros. & Sons).
 Log in
Top
Inflammopharmacology

Pharmaceutical aspects of JAK inhibitors: a comparative review

Published in:
Authors
Sandhya Jinesh
Rajan Radhakrishnan
Published in
Inflammopharmacology | Issue 1/2025

Abstract

Janus kinase inhibitors (JAKIs) are a new class of drugs used in the treatment of a heterogeneous group of diseases, mainly inflammatory and autoimmune diseases. Janus kinase (JAK) is a family of non-receptor tyrosine kinases in cells that transduce cytokine-mediated signals. JAK, along with signal transducer and activator of transcription (STAT) protein, mediate important cellular processes such as immune response, carcinogenesis, cell differentiation, cell division, and cell death. Therefore, inhibitors of JAK-STAT signaling pathways could be useful in treating conditions mediated by the above-mentioned processes. JAK inhibitors mainly treat inflammatory and/or autoimmune diseases such as rheumatoid arthritis, psoriasis, and atopic dermatitis. In this review, we tried to focus on the discovery, pharmacology, and pharmaceutical aspects of JAK inhibitor drugs and their relative risks and benefits, especially focusing on the adverse effects of this class of drugs.
Title
Pharmaceutical aspects of JAK inhibitors: a comparative review
Authors
Sandhya Jinesh
Rajan Radhakrishnan
Publication date
10-12-2024
Publisher
Springer International Publishing
Published in
Inflammopharmacology / Issue 1/2025
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-024-01614-9
This content is only visible if you are logged in and have the appropriate permissions.

Other articles of this Issue 1/2025

Mechanisms and clinical applications of palmitoylethanolamide (PEA) in the treatment of neuropathic pain

Effects of the anti-inflammatory pentoxifylline on psychiatric and neuropsychiatric conditions: exploring various off-label utilities with meta-analyses

Stimulation, regulation, and inflammaging interventions of natural compounds on nuclear factor kappa B (NF-kB) pathway: a comprehensive review

  • Review

Recent advancements in drug delivery system of flavonoids with a special emphasis on the flavanone naringenin: exploring their application in wound healing and associated processes

  • Review

A randomized clinical study to evaluate the possible antifibrotic effect of zinc sulfate in chronic HCV patient receiving direct-acting anti-viral therapy

Esculin-loaded nanoparticles ameliorate adjuvant-induced polyarthritis via subduing inflammatory and oxidative stress biomarkers in Wistar rats